Mobile

RANDOMIZED, DOUBLE-BLIND, MULTICENTER STUDY OF THE EFFICACY, TOLERABILITY AND SAFETY OF VALDECOXIB (BEXTRA®)10 MG OD VS. DICLOFENAC SODIUM 50 MG TDS FOR 6 WEEKS IN SUBJECTS WITH OSTEOARTHRITIS OF THE ...

Update Il y a 4 ans
Reference: EUCTR2004-001713-34

RANDOMIZED, DOUBLE-BLIND, MULTICENTER STUDY OF THE EFFICACY, TOLERABILITY AND SAFETY OF VALDECOXIB (BEXTRA®)10 MG OD VS. DICLOFENAC SODIUM 50 MG TDS FOR 6 WEEKS IN SUBJECTS WITH OSTEOARTHRITIS OF THE KNEE

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

The primary objective of this study is to demonstrate that valdecoxib 10 mg administered once daily for 6 weeks is not inferior to diclofenac sodium 50 mg administered three times daily for a total daily dose of 150 mg for 6 weeks in treating the signs and symptoms of OA of the knee.

Inclusion criteria

  • Osteoarthritis of the knee

Links